Baker Avenue Asset Management, LP
Position in CRL — Charles River Laboratories International, Inc.
CIK 1432529
SAN FRANCISCO, CA
Position in CRL
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$342,679
+$72,372 QoQ
Shares Held
1,511
-3.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#349
of 569 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Baker Avenue Asset Management, LP holds $28,937,634 across 12 Diagnostics & Research names. CRL ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
35,467 | $17,781,735 | |
| 2 | A |
Agilent Technologies, Inc.
|
43,641 | $5,796,834 | |
| 3 | DHR |
Danaher Corp /De/
|
5,929 | $1,129,355 | |
| 4 | ILMN |
Illumina, Inc.
|
5,692 | $1,000,824 | |
| 5 | NTRA |
Natera, Inc.
|
2,915 | $791,276 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,257 | $661,735 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,346 | $453,294 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
This page
|
1,511 | $342,679 |
All Filings in CRL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $342,679 | 1,511 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $270,307 | 1,567 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $343,704 | 1,723 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $284,131 | 1,816 | Shares | Sole | 2025-10-31 | |
| 2023-09-30 | $11,562 | 59 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $630 | 3 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $6,319 | 29 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||